Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Assets
Cash and cash equivalents	$ 329,011	$ 277,696
Receivables	69,276	51,592
Real estate inventories	3,065,436	3,216,059
Investments in unconsolidated entities	11,745	5,410
Goodwill and other intangible assets, net	159,893	160,427
Deferred tax assets, net	49,904	67,768
Other assets	173,425	105,251
Total assets	3,858,690	3,884,203
Liabilities
Accounts payable	66,120	81,313
Accrued expenses and other liabilities	322,043	335,149
Loans payable	250,000	0
Senior notes, net	1,033,985	1,410,804
Total liabilities	1,672,148	1,827,266
Commitments and contingencies
Stockholders’ Equity:
Preferred stock, $0.01 par value, 50,000,000 shares authorized; no shares issued and outstanding as of December 31, 2019 and 2018, respectively	0	0
Common stock, $0.01 par value, 500,000,000 shares authorized; 136,149,633 and 141,661,713 shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively	1,361	1,417
Additional paid-in capital	581,195	658,720
Retained earnings	1,603,974	1,396,787
Total stockholders’ equity	2,186,530	2,056,924
Noncontrolling interests	12	13
Total equity	2,186,542	2,056,937
Total liabilities and equity	$ 3,858,690	$ 3,884,203